GI
Grifols, S.A.
GIFOF · OTC
$8.85 +0.00% (+$0.00)
Market Cap 7.58B €
P/E Ratio 16.77x
Div. Yield 3.18%
ROE 8.43%
Bulios Fair Price
$12.05
36.2% upside
Trenutna cena
$8.85
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica GIFOF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
7/9Valuation
89 /100
Cheap P/E 16.77x
PEG 0.12x
EV/EBITDA 9.64x
Growth
66 /100
Stable EPS growth 23.93%
Book val. growth 4.91%
Rev. growth 7.44%
Profitability
64 /100
Moderate Gross margin 37.23%
FCF margin 10.32%
Net margin 6.09%
Quality
31 /100
Poor ROIC 5.48%
Asset turnover 0.37x
ROE 8.43%
Debt
34 /100
Moderate Debt/Equity 1.54x
Net debt/EBITDA 4.95x
Current ratio 2.37x
Stability
61 /100
Moderate Beta 1.19x
Profitable years 6
Rev. volatility 2.78%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o GIFOF
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Jose Ignacio Abia Buenache
Employees
25,258
Headquarters
Barcelona
Prihajajoči dogodki
10 NOV.
Earnings
Upcoming earnings report